Selling IPL Hair Removal Devices Overseas: How Regulations Differ by Market
Registration and compliance requirements for IPL hair removal devices in the US, EU, and Asia-Pacific markets, explained in one article.
Citable Summary
What is this article about?
A home IPL device is a Class II medical device in the US, carrying product code OHT in the FDA classification database, while the same device enters the EU under MDR 2017/745 as Class IIa or IIb depending on intended use. Class sets how much testing and documentation is required, so the target market sets the timeline.
The same IPL hair removal device requires a completely different set of procedures depending on the country you sell it to. As an OEM/ODM manufacturer, wherever the product ships, regulations have to be scheduled in early. The first thing when going overseas is to understand how your target market classifies it.
The US treats home IPL hair removal devices as Class II medical devices. In the FDA’s product classification database, this device type carries product code OHT, under the category name Light Based Over-The-Counter Hair Removal — the classification page is publicly searchable. Before market entry you have to clear the FDA gate, either through the 510(k) pathway or, depending on the device’s technical characteristics, through premarket approval (PMA) — which route you take depends on the machine itself. The label has to be complete: directions for use, indications, contraindications, warnings, and precautions, none missing. Establishment registration and device listing also go through the FDA.
The EU is a different system. The CE mark is based on the Medical Device Regulation MDR 2017/745, and products are classified into Class IIa or IIb depending on intended use. The regulation has applied across the EU since May 26, 2021, replacing the old Medical Devices Directive 93/42/EEC, and the full regulation text is public on EUR-Lex. Getting the certificate means passing a notified body, which reviews the technical file — including clinical evaluation, risk management per ISO 14971, and the quality system built per ISO 13485.
The Asia-Pacific market is the most fragmented — every country has its own rules. Let me just lay it out in a table.
| Market | Regulator | Key points |
|---|---|---|
| Japan | PMDA | Registration required; risk classification under the Pharmaceuticals and Medical Devices Act |
| South Korea | MFDS | Approval required; new devices may need clinical data |
| China | NMPA | Registration plus compliance with GB standards; domestic testing often required |
| Australia | TGA | ARTG listing; some overseas approvals recognized |
| Southeast Asia | Varies by country | Some accept CE; others require local registration and testing |
Scan the table horizontally and you’ll notice a pattern. The same product definition can land in different classes in different markets, and once the class is set, the amount of testing and documentation required is determined. That’s why we usually advise clients to list their target markets one by one at the project scoping stage. The earlier the markets are set, the earlier the test plan and documentation list are scheduled, and the less rework there is later.
There’s no shortcut in regulation, but it’s not mystical either. Work out the pathway for each market, complete the required tests in order, and the launch timeline writes itself.
Need a project-specific answer?
Talk to our manufacturing team
Contact the team to discuss your market, volume, compliance needs, and product direction.
Last updated
Did you find this article helpful?
Related articles
Continue reading
Do You Need a Canadian MDL for an IPL Hair Removal Device? The Licence Data Says No
Read →
EU MDR for Home IPL Hair Removal Devices: Only One Company Has the Certificate
Read →